Paradigm Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.7K | Hold |
176
| – | – | 0.01% | 445 |
|
|
2025
Q1 | $26.5K | Hold |
176
| – | – | 0.01% | 457 |
|
|
2024
Q4 | $32.5K | Hold |
176
| – | – | 0.01% | 437 |
|
|
2024
Q3 | $34.7K | Hold |
176
| – | – | 0.01% | 431 |
|
|
2024
Q2 | $36.4K | Hold |
176
| – | – | 0.01% | 432 |
|
|
2024
Q1 | $47.7K | Hold |
176
| – | – | 0.01% | 430 |
|
|
2023
Q4 | $41.6K | Hold |
176
| – | – | 0.01% | 444 |
|
|
2023
Q3 | $34.5K | Hold |
176
| – | – | 0.01% | 484 |
|
|
2023
Q2 | $37K | Hold |
176
| – | – | 0.01% | 437 |
|
|
2023
Q1 | $35.5K | Hold |
176
| – | – | 0.01% | 428 |
|
|
2022
Q4 | $38.4K | Sell |
176
-2,600
| -94% | -$567K | 0.01% | 436 |
|
|
2022
Q3 | $546K | Hold |
2,776
| – | – | 0.18% | 219 |
|
|
2022
Q2 | $594K | Hold |
2,776
| – | – | 0.18% | 218 |
|
|
2022
Q1 | $788K | Hold |
2,776
| – | – | 0.21% | 175 |
|
|
2021
Q4 | $1.05M | Buy |
2,776
+176
| +7% | +$66.3K | 0.26% | 145 |
|
|
2021
Q3 | $1.07M | Sell |
2,600
-100
| -4% | -$41.3K | 0.29% | 120 |
|
|
2021
Q2 | $999K | Hold |
2,700
| – | – | 0.26% | 157 |
|
|
2021
Q1 | $783K | Sell |
2,700
-100
| -4% | -$29K | 0.21% | 214 |
|
|
2020
Q4 | $700K | Buy |
+2,800
| New | +$700K | 0.2% | 204 |
|
|
2016
Q3 | – | Sell |
-1,600
| Closed | -$132K | – | 676 |
|
|
2016
Q2 | $132K | Hold |
1,600
| – | – | 0.02% | 374 |
|
|
2016
Q1 | $122K | Sell |
1,600
-3,100
| -66% | -$235K | 0.02% | 389 |
|
|
2015
Q4 | $378K | Buy |
+4,700
| New | +$378K | 0.07% | 279 |
|